Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

The Risky Business of Fungal Infections in Patients with Cirrhosis

Brumble, Lisa MD, FIDSA1; Keaveny, Andrew P MD, FRCPI, FAASLD2

American Journal of Gastroenterology: April 2018 - Volume 113 - Issue 4 - p 564–566
doi: 10.1038/ajg.2018.20
ORIGINAL CONTRIBUTIONS: LIVER: EDITORIAL
Buy

Hospitalized patients with cirrhosis have a high rate of mortality. In the report by Bajajet al., the negative impact of fungal infections (FI) on outcomes in a large US cohort of hospitalized cirrhotics is highlighted. Risk factors for FI are identified. Increasing awareness of FI along with the application of new diagnostic tools in species identification will provide the opportunity to improve patient outcomes.

1Department of Medicine, Division of Infectious Disease, Mayo Clinic, Jacksonville, Florida, USA

2Department of Transplant, Mayo Clinic, Jacksonville, Florida, USA

Correspondence: Andrew P. Keaveny, MD, FRCPI, FAASLD, Department of Transplant, Mayo Clinic, 4500 San Pablo Road, Jacksonville, Florida 32224, USA. E-mail: keaveny.andrew@mayo.edu

Received 1 January 2018; accepted 5 January 2018

© The American College of Gastroenterology 2018. All Rights Reserved.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website